Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sylvie Rusakiewicz
Phase I Clinical Trial Combining Imatinib Mesylate and IL-2
OncoImmunology
Oncology
Allergy
Immunology
Related publications
Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial
The Lancet Oncology
Oncology
A Dose-Escalating Phase I of Imatinib Mesylate With Fixed Dose of Metronomic Cyclophosphamide in Targeted Olid Tumours
British Journal of Cancer
Cancer Research
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
Cancer
Cancer Research
Oncology
Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Imatinib Mesylate Causes Growth Plate Closure in Vivo
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Imatinib Mesylate Inhibits Fibrogenesis in Asbestos-Induced Interstitial Pneumonia
Experimental Lung Research
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Molecular Biology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Evaluation of Wearable Digital Devices in a Phase I Clinical Trial
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics